Intragastric Balloon Market Growth and Share, Emerging Trends, Scope, Top Manufactures, CAGR Status, Business Challenges, Future Opportunities 2033: SPER Market Research

Gastric balloon surgery, a recent method for weight loss, aims to help individuals eat smaller meals and feel satisfied for longer periods. This non-surgical procedure, also known as intragastric balloon, involves placing a silicone balloon filled with saline or gas in the stomach to control food intake and promote weight loss. Since 1985, intragastric balloons have been widely used as a means to address obesity and facilitate the process of losing weight.

According to SPER market research, ‘Intragastric Balloon Market Size- By Type, By Administration, By Filling Material, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033’ state that the Global Intragastric Balloon Market is predicted to reach USD 0.38 billion by 2033 with a CAGR of 17.31%.

Several variables influence the market for intragastric balloons. The first main driving driver is the rising prevalence of obesity worldwide, which increases demand for weight loss interventions as more people become affected by obesity-related health problems. Intragastric balloon techniques’ non-surgical approach appeals to people looking for less intrusive weight loss options than invasive surgeries. Intragastric balloon treatments are in high demand as a result of increased attention on weight management and growing awareness of the health hazards associated with obesity. By enhancing patient outcomes and satisfaction, technological improvements including better materials and greater safety features support market expansion.

The intragastric balloon market does, however, confront difficulties. Limited long-term efficacy is a worry since, if lifestyle adjustments are not maintained, people may experience weight gain after the balloon is removed. Patient safety and satisfaction may be impacted by potential side effects and complications such nausea, vomiting, and stomach ulcers. Accessibility problems stem from cost and reimbursement, especially in areas with scant insurance coverage or reimbursement choices. The rivalry from surgical weight loss methods, which provide more significant and durable results, also poses a problem for the uptake of intragastric balloons. For the intragastric balloon industry to continue to expand steadily, it will be essential to overcome these obstacles and address long-term efficacy, safety, cost, and competition.

Request For Free Sample Report @ https://www.sperresearch.com/report-store/Global-Intragastric-Balloon-Market-Analysis.aspx?sample=1

The COVID-19 epidemic has had a substantial effect on the intragastric balloon market globally. Affected by the outbreak were healthcare systems and elective operations, among other non-essential medical treatments. The amount of intragastric balloon procedures carried out throughout the pandemic decreased as a result of this. Intragastric balloon production and distribution were also hampered by logistical issues and supply chain disruptions. But as things start to get better, the market is predicted to recover because of the renewed interest in elective treatments and the increased attention being paid to weight management. The effects over the long term will be influenced by variables like vaccination rates, containment measure efficacy, and the global healthcare system’s ability to recover.

Geographically, North America holds a prominent position in the intragastric balloon market, primarily driven by a rising obese population and the widespread adoption of weight loss treatments in the region. On the other hand, the Asia-Pacific region is anticipated to exhibit the highest growth rate during the forecast period. This growth can be attributed to factors such as the adoption of unhealthy lifestyles, an increasing prevalence of obesity, and the availability of affordable therapies. Additionally, some of the market key players are Allurion Technologies, Inc., Obalon Therapeutics, Inc., ReShape Medical, Inc., Spatz3, others.